The Worldwide Market for In Vitro Diagnostic Tests, 7th Edition
In seven best-selling editions, Shara Rosen has provided a total view of every aspect
of the market for in vitro diagnostic (IVD) testing in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, stands as a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. Market numbers for business planning matched with a discovery of the trends that are impacting the industry. A realistic forecast five years into the future for companies already participating in or considering entry into this growing industry. The idea behind Kalorama's unique report is that the entire market can be captured in one volume and business planners can use it as a key reference. Published every two years, this volume includes coverage of the most important aspects of all of the major segments of clinical lab testing, including:
Point of Care (POC), (Professional and Self-Testing)
Core Lab (General Chemistries, Workstations, Analyzers)
Immunoassays (Blood Gases, Urinalysis, Critical Care)
Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
Hematology
Coagulation (Lab-Based, POC, Genetic Markers)
Microbiology and Virology
Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
Histology and Cytology (Pap, ISH, IHC, traditional non-pap, HPV)
For each of these sections, Shara Rosen reviews the key products dominating the market segment, the innovations that are occurring, trends that are impacting the segment. Market size, and forecast and market share are provided; and discussion of regional numbers of the segment is provided where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market is provided for 2009; projections are made through 2014.
Kalorama Information's Report - The Bible of the IVD Industry'
Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. These are the numbers that it is very likely competitive companies will be using in their planning.
This 900+ page edition greatly expands coverage of the field and tracks the most important developments.
A Global Report
IVD is a worldwide business. While the US is a large healthcare market, much of the dynamism occurs in other areas. Many of the most interesting developments are occurring in emerging markets. As part of its coverage, the report breaks down the entire IVD market for the following regions.
North America
Europe (EU)
Eastern Europe
South America
Asia (China and India as subsegments)
Rest of World
A Report Designed for a Changing Industry
In this seventh edition of The Worldwide Market for In Vitro Diagnostic Tests Kalorama Information has reorganized the presentation of the IVD market in a manner that better reflects how the industry has evolved.
In the past, molecular testing was a small emerging discipline that related to chlamydia, gonorrhea, TB, and some inherited diseases. Now molecular technologies are impacting several areas of diagnostics. Molecular diagnostics has its own chapter but also is present in those other areas. Trends such as pharmacodiagnostics, molecular poc and test services are put in a context.
The report's approach reflects the increasing use of automation in the lab; core lab section includes both workstation and automated panel revenues.
The reports profiles distinguish between companies that are leaders in all aspects of IVD, those that lead in one particular area or a few, and those that are innovative but not yet large.
We track laggards' - companies from the past few years that have failed due to financing or product failure.
IVD Companies have been busy. The report examines the major mergers as well as partnerships, distribution agreements.
A comparison and contrast of India and China - important emerging markets for IVD. But not always well-understood ones.
There is discussion of the role of the new government focus on EMR and how it impacts IVD devices.
Healthcare statistics for various countries -healthcare spending as a percent of GDP, new hospitals, cost increases and other information.
Tables that document the innovative products being developed in each area of IVD.
Country-level Breakout of IVD market for major European and Asian countries.
The Impact of US Health Care Reform
The Spread of Wireless Diagnostics and Remote Monitoring
New Screening Guidelines and Market Impact
Chronic vs. Infectious Disease
Strange Bedfellows? Analysis fn the IVD Industry Consolidation
The Continued Molecularization of Devices
The Current Economic Situation: Recession: Post-Recession?
The report looks at where non-Invasive Sampling
PGx and SNP Testing
IVD and the Promise of Personalized Medicine has been a discussion for years. Now it is closer to reality.
The report provides an Update on the Regulation of Novel Devices
Focus on the Continued Fight against Nosocomial Infections
Innovations in Blood Banking
Histology/Cytology innovations; the role of FISH testing and Digital Images
Extensive IVD Company Profiles
The report covers companies that are established leaders in in vitro diagnostics, companies that dominate a specialty area and those that have very innovative or promising approaches. Over two hundred companies are profiled in the The Worldwide Market for In Vitro Diagnostics; among those companies profiled:
Abbott Diagnostics
ARKRAY
Becton, Dickinson and Company (BD)
Beckman Coulter Inc.
bioMrieux Inc.
Bio-Rad Laboratories Inc.
Gen-Probe Inc.
Hologic, Inc.
Instrumentation Laboratory (IL)
Inverness Medical Innovations
Ortho Clinical Diagnostics
QIAGEN N.V.
Radiometer A/S
Roche Diagnostics
Siemens Healthcare Diagnostics
Sysmex Corporation
Thermo Fisher Scientific Inc.
Affymetrix, Inc.
Agendia BV
Axis-Shield plc
Bio-Reference Laboratories, Inc. (BRLI)
Bruker BioSciences Corporation
Celera Diagnostics
Cepheid
Clarient Inc.
Clinical Data, Inc.
Danaher Corporation
DiaSorin S.p.A.
Eiken Chemical Co., Ltd
ELITech Group
Fujirebio Diagnostics, Inc.
Genomic Health, Inc.
Genzyme Genetics
Innogenetics NV
International Technidyne Corp (ITC)
IRIS International, Inc.
Laboratory Corporation of America Holdings (LabCorp)
Life Technologies
Luminex Corporation
Magellan Biosciences
A. Menarini Diagnostics
Mindray Bio-Medical Electronics Co., Ltd
Monogram Biosciences, Inc.
Myriad Genetics, Inc.
Nanosphere, Inc.
Nova Biomedical
PerkinElmer, Inc.
Phadia AB
Quest Diagnostics
Quidel Corporation
Randox Laboratories Ltd.
Rosetta Genomics Ltd.
Sequenom
Third Wave Technologies Inc.
TOSOH Corporation
Trinity Biotech plc
Veridex, LLC
Werfen Group S.A.
3M Medical Diagnostics
AcroMetrix
Advanced Liquid Logic, Inc.
AltheaDx Technologies, Inc.
AMDL Diagnostics, Inc. (ADI)
Arrayit Diagnostics Inc.
AviaraDx (formerly Arcturus Biosciences)
Biocare Medical LLC
Biotage AB
bioTheranostics
BioTrove, Inc.
China Medical Technologies, Inc.
DxS Ltd.
Envision ALR
Epigenomics AG
Exosome Diagnostics Inc.
Grifols, S.A.
Idaho Technology Inc.
iKaryos Diagnostics
Interleukin Genetics, Inc.
Intrinsic Bioprobes Inc.
Ionian Technologies, Inc.
Linkage Biosciences, Inc
Millipore Corporation
Nanogen Inc.
OncoMethylome Sciences S.A.
OPTI Medical Systems
OptiGene Ltd
Polymedco, Inc.
Saladax Biomedical, Inc. (SBI)
SensiGen LLC
Source MDx
Spartan Bioscience Inc.
SQI Diagnostics Inc.
TessArae, LLC
Transgenomic Inc.
TrimGen Corporation
TrovaGene, Inc.
Vermillion Inc.
Wako Pure Chemical Industries, Ltd.
AbSorber AB
Arteriocyte, Inc.
Biotest AG
CaridianBCT Inc.
Cerus Corporation
Daxor Corporation
Fenwal Inc.
Immucor, Inc.
IntelliDOT Corp.
Novartis Vaccines and Diagnostics/Chiron
Progenika Inc.
Quotient Biodiagnostics Inc.
Verax Biomedical Inc.
Accumetrics
Corgenix Medical Corporation
Diagnostica Stago
AgaMetrix, Inc.
Bayer Diabetes Care
Animas Corporation
Bionime Corporation
BodyTel Scientific, Inc.
DexCom, Inc.
Diabetech, LP
Diagnostic Devices, Inc.
Entra Health Systems
Fora Care
Home Diagnostics, Inc.
Insulet Corporation
Lifescan Inc.
Medtronic Inc.
OrSense Ltd.
Smiths Medical MD, Inc.
Solianis Monitoring AG
Burnet Institute
CellaVision AB
Chempaq A/S
Guava Technologies, Inc.
Horiba Medical
Partec GmbH
PointCare Technologies
QBC Diagnostics, Inc.
Zyomyx Inc.
Aperio Technologies, Inc.
BioImagene
Celerus Diagnostics
Compucyte Corporation
CytoCore, Inc.
Dako A/S
Expression Pathology Inc.
Genetix Applied Imaging
HistoRx, Inc.
Ikonisys, Inc.
InterGenetics Inc.
mtm laboratories AG
Pathwork Diagnostics
Vision BioSystems Ltd
Adlyfe, Inc.
Akers Biosciences, Inc.
Amorfix Life Sciences Ltd.
Atherotech
Avioq, Inc.
Axela Biosensors, Inc.
BG Medicine Inc.
Biomerica Inc.
BioPorto A/S
BioSystems International
BRAHMS Aktiengesellschaft
CeMines, Inc.
Concateno Plc
Cylex Incorporated
Decision Biomarkers Inc.
Immunodiagnostic Systems Ltd.
Innotrac Diagnostics Oy
Inova Diagnostics Inc.
IVAX Diagnostics, Inc.
LifeAssays AB
Meridian Bioscience, Inc.
Miraculins Inc.
Ridge Diagnostics, Inc.
Shanghai Kehua Bio-engineering
SpectraCell Laboratories, Inc.
3QBD
Accelr8 Technology Corporation
Advanced Analytical Technologies Inc.
AdvanDx, Inc.
bioLytical Laboratories
BioVei Incorporated
Cellestis Ltd
Chembio Diagnostic Systems, Inc.
Copan Diagnostics Inc.
Diagnostic HYBRIDS, Inc.
Dynacon Inc.
eGenomics, Inc.
Enigma Diagnostics Limited
Focus Diagnostics, Inc.
GlysBy
Hain Lifescience GmbH
Innovotech Inc.
Liofilchem s.r.l.
MicroPhage, Inc.
Mobidiag Oy
Molzym GmbH & Co. KG
Myconostica, Ltd.
Oxoid
Pocared Diagnostics Ltd
Prodesse Inc.
SIRS-Lab
SmartGene GmbH
TheraDoc
TREK Diagnostic Systems
Tyrian Diagnostics Limited
Veredus Laboratories Pte
ViraCor Laboratories
VIRCO BVBA
Advanced Analytical Technologies, Inc.
Arcxis Biotechnologies
AutoGenomics, Inc.
BioHelix Corporation
CyGene Laboratories Inc.
DioGenix, Inc.
DNage
GeneNews Limited
Ipsogen
KREATECH Biotechnology B.V.
Med BioGene, Inc.
Microchip Biotechnologies, Inc.
OncoMethylome Sciences S.A.
Orchid Cellmark
Orion Genomics
Psynomics Incorporated
Rubicon Genomics, Inc.
Tepnel Life Sciences
TwistDx, Ltd.
WaferGen Biosystems, Inc.
Xceed Molecular
77 Elektronika Kft.
A/C Diagnostics
Acon Laboratories, Inc.
Acrongenomics Inc.
Amic AB
BioIQ
ContraVac, Inc.
HemoCue AB
Identa Corporation
Philips Electronics NV
QuantRx Biomedical Corporation
Screening Devices Canada, Inc.
Sphere Medical Ltd.
Soar BioDynamics, Ltd.
VeriChip Corporation
Vital Diagnostics
To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/6013/The-Worldwide-Market-for-In-Vitro-Diagnostic-Tests-7th-Edition.html
Contact us:
Visionshopsters
Ph : 91-22-40583020
Email: marketing@visionshopsters.com
Website : www.visionshopsters.com
The Worldwide Market for In Vitro Diagnostic Tests, 7th Edition
By: Visionshopstersindia
Labeling Options Offer Marketing, Production Advantages Atlantic Toyota and Huntington Toyota Excited about Scion Marketing Forex alerts are a handy way of staying on top of the market The forex market uses margins to increase your profits I've Been In The Cash Gifting And Interent Marketing Arena For Years Mark 2 Market Bpo - Effective Use of Telemarketing Email Marketing Article From Brianclarkmethod.com Determining Your Online Marketing Strategy Push and Pull Marketing Full Sail U Online Marketing Degree Inteligator Scam Surefire Trading Challenge Scam Steal Pips Scam